ALEC Alector, Inc.
Healthcare$2.21+0.00%ClosedMarket Cap: $245.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
23.54
P/S
13.32
EV/EBITDA
-1.63
DCF Value
$-0.20
FCF Yield
-70.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
88.7%
Operating Margin
-741.3%
Net Margin
-680.8%
ROE
-295.2%
ROA
-52.3%
ROIC
-65.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.0M | -99.2% | $-25.2M | $-22.9M | $— | — |
| Q4 null | $6.2M | 100.0% | $-39.6M | $-37.3M | $— | — |
| FY null | $21.0M | 54.1% | $-145.8M | $-142.9M | $— | — |
| Q3 null | $3.3M | 100.0% | $-37.6M | $-34.7M | $— | — |
| Q2 null | $7.9M | 100.0% | $-34.1M | $-30.5M | $— | — |
| Q1 null | $3.7M | 100.0% | $-44.7M | $-40.5M | $— | — |
| Q4 null | $54.2M | 14.3% | $-7.2M | $-2.1M | $— | — |
| FY null | $100.6M | 100.0% | $-145.0M | $-119.0M | $— | — |
| Q3 null | $15.3M | 100.0% | $-48.4M | $-42.2M | $— | — |
| Q2 null | $15.1M | 84.9% | $-45.6M | $-38.7M | $— | — |
| Q1 null | $15.9M | 85.6% | $-43.7M | $-36.1M | $— | — |
| Q4 2023 | $15.2M | 85.1% | $-47.5M | $-41.4M | $-0.49 | — |